Summary Book Renal Flashcards

1
Q

DDx of kidney enlargement

A

Chronic hydronephrosis, renal cell carcinoma, acromegaly, polycystic kidneys, infiltrative = amyloidosis / sarcoidosis / malignancy - lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contraindications for renal transplant

A

Malignant disease (<2years of remission). Severe ILD and lung disease. Active vasculitis. Ongoing sepsis / TB / HIV. Alcohol, smoking, drugs. Severe osteoporosis or uncontrolled diabetes. Over 75 years old. Over 35 BMI. Medication non compliance or physciatric instability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complications of calcineurin inhibitors (tacrolimus, cyclosprin)

A

Tremor, AKI, hypertension, hyperglycemia, hyperkalemia, deranged LFT, gingival hyperplasia, hirsutism, gout, haematological malignancy, SCC, post transplant lymphoproliferative disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Complications of sirolimus (mtor inhibitor)

A

Hyperlipidaemia, proteinuria, infection, ILD, pulmonary effusion, pericardial effusion, DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mycophenolate complications

A

Nausea, vomiting, diarrhoea, pancytopnea, infections, SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Azathioprine complications

A

Hepatitis, rash, pancreatitis, TPMT levels, SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Steroid complications

A

Diabetes, weight gain, osteoporosis, myopathy, bruising, infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define, cause and management of post transplant lymphoproliferative disorder

A

B cell proliferation becoming lymphoma. EBV status. Reduce immunosuppressants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of renal transplant

A
  1. Immunosuppressant- prednisolone/ tacrolimus/ MMF - wean CNI after 6 months. 2. Monitor for signs of pharmacological side effects. 3. If CMV positive then 6 months of valganciclovir. 4. Bactrim for PJP. 5. Annual vaccination and skin checks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for renal transplant

A

Diabetes, glomerulonephritis, hypertension, SLE, IHD, PVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs of rejection

A

Fevers, swelling, reduced urine output, flank pain, acute renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Complications of dialysis

A

Hypotension, peritonitis, dementia, line infection, social (sexual dysfunction, financial, work)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pros and cons of haemodialysis and peritoneal dialysis.

A

Peritoneal dialysis- risk of peritonitis, protein loss, hyperglycemia, not as effective, perforation. HD- less total time, less protein loss, access issues (infections or clots), hypotension, amyloid, anaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for acute dialysis

A

Uraemia, fluid overload, hyperkalemia, severe metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Protective and mortality factors for dialysis

A

Protective- high cholesterol and obesity. Mortality- high phosphate, low albumin, hypertension and diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of CKD complications

A
  1. Treat reversible conditions (diabetes, UTI, hypertension, drugs, CCF, dehydration)
  2. Non pharmacological- fluid restriction, optimise CVS health, transplant work up
  3. Pharmacological- monitor bone health = calcium and phosphate levels, aneamia, renal osteodystrophy (vit D)
    Bicarb can be considered for metabolic acidosis.
    ACEi for hypoalbuminaemia and hypertension
17
Q

Investigations for chronic kidney disease

A
  1. Bloods - FBC, UEC, albumin, myoloma screen, vasculitis screen
  2. GN screen - ANA, ENA, dsDNA, C3+4, ANCA (MPO/PR3), anti GBM antibodies
  3. Urinalysis- ACR (<30mg/g), casts, blood
  4. Us or CT KUB
  5. Biopsy to rule out GN
18
Q

Risk factors of chronic kidney disease

A

Diabetes (33%), glomerulonephritis (24%), hypertension (14%), systemic disease (vasculitis, RF, myoloma, infective endocarditis), polycystic kidney disease, reflux nephropathy, drugs

19
Q

Presentation of chronic renal impairment

A

Anaemia, ureamia (lethargy, nausea, vomiting, anorexia, fatigue, cramps, confusion), puritis, peripheral neuropathy, pericarditis, nocturia

20
Q

Compare mechanisms of calcitriol and cinacalcet

A

Calcitriol (active vit D) lowers PTH levels, which reduces turnover, and increases calcium while decreasing phosphate
Cinacalcet increases sensitivity of calcium sensing receptors of PTH which decreases calcium

21
Q

Compare definitions and presentation of nephritic and nephrotic

A

Nephrotic = > 3.5g of protein and low albumin. Presents with oedema, hyperlipidaemia and hypercoagulant
Nephritic = presents with AKI, hypertension, haematuria, proteinuria and pyuria.